356
Views
42
CrossRef citations to date
0
Altmetric
Orginal Articles

In vitro toxicity of functionalised nanoclays is mainly driven by the presence of organic modifiers

, , , , , , & show all
Pages 279-294 | Received 28 Jun 2012, Accepted 06 Feb 2013, Published online: 11 Mar 2013

References

  • Atai M, Solhi L, Nodehi A, Mirabedini SM, Kasraei S, Akbari K, 2009. PMMA-grafted nanoclay as novel filler for dental adhesives. Dent Mater 25:339–347.
  • Baek M, Kim IS, Yu J, Chung HE, Choy JH, Choi SJ. 2011. Effect of different forms of anionic nanoclays on cytotoxicity. J Nanosci Nanotechnol 11:1803–1806.
  • Bernstein JA, Stauder T, Bernstein DI, Bernstein IL. 1994. A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary amines. J Allergy Clin Immunol 94:257–259.
  • Choi SJ, Oh JM, Choy JH. 2008. Safety aspect of inorganic layered nanoparticles: size-dependency in vitro and in vivo. J Nanosci Nanotechnol 8:5297–5301.
  • Christidis G, Dunham AC. 1993. Compositional variations in smectites. Part I: alteration of intermediate volcanic rocks. A case study from Milos Island, Greece. Clay Minerals 28:255–173.
  • Christidis G, Dunham AC. 1997. Compositional variations in smectites. Part II: Alteration of acidic precursors, a case study from Milos Island, Greece. Clay Minerals 32:253–270.
  • Cronholm P, Midander K, Karlsson HL, Elihn K, Wallinder IO, Möller L. 2011. Effect of sonication and serum proteins on copper release from copper nanoparticles and the toxicity towards lung epithelial cells. Nanotoxicology 5(2):269–281.
  • Cui L, Khramov DM, Bielawski CW, Hunter DL, Yoon PJ, Paul DR. 2008. Effect of organoclay purity and degradation on nanocomposite performance, Part 1: surfactant degradation. Polymer (Guildf) 49:3751–3761.
  • De Azeredo HMC. 2009. Nanocomposites for food ackaging applications. Food Res Int 42:1240–1253.
  • Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–495.
  • Dong PX, Wan B, Guo LH. 2012. In vitro toxicity of acid-functionalized single-walled carbon nanotubes: effects on murine macrophages and gene expression profiling. Nanotoxicology 6:288–303.
  • Elban WL, Howarter JA, Richardson MC, Stutzman PE, Forster AM, Nolte AJ, 2012. Influence of solvent washing on interlayer structure of alkylammonium montmorillonites. Appl Clay Sci 61:29–36.
  • George S, Lin S, Ji Z, Thomas CR, Li L, Mecklenburg M, 2012. Surface Defects on Plate-Shaped Silver Nanoparticles Contribute to Its Hazard Potential in a Fish Gill Cell Line and Zebrafish Embryos. ACS Nano 6:3745–3759.
  • He H, Duchet J, Galy J, Gérard JF. 2006. Influence of cationic surfactant removal on the thermal stability of organoclays. J Colloid Interface Sci 295:202–208.
  • Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, 2010. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol 7:36.
  • Hitosugi M, Maruyama K, Takatsu A. 1998. A case of fatal benzalkonium chloride poisoning. Int J Legal Med 111:265–266.
  • International Programme on Chemical Safety (IPCS). 1999. Poisons Information Monograph G022.
  • Jiang J, Oberdörster G, Biswas P. 2009. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:77–89.
  • Jover R, Ponsoda X, Castell JV, Gómez-Lechón MJ. 1992. Evaluation of the cytotoxicity of ten chemicals on human cultured hepatocytes: Predictability of human toxicity and comparison with rodent cell culture systems. Toxicol In Vitro 6:47–52.
  • Kermanizadeh A, Gaiser BK, Ward MB, Stone V. 2012. Primary human hepatocytes versus hepatic cell line: assessing their suitability for in vitro nanotoxicology. Nanotoxicology doi:10.3109/17435390.2012.734341.
  • Lankoff A, Arabski M, Wegierek-Ciuk A, Kruszewski M, Lisowska H, Banasik-Nowak A, 2012. Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro. Nanotoxicology doi:10.3109/17435390.2011.649796.
  • Li PR, Wei JC, Chiu YF, Su HL, Peng FC, Lin JJ. 2010. Evaluation on cytotoxicity and genotoxicity of the exfoliated silicate nanoclay. ACS Appl Mater Interfaces 2:1608–1613.
  • Lordan S, Higginbotham CL. 2012. Effect of serum concentration on cytotoxicity of clay particles. Cell Biol Int 36:57–61.
  • Lordan S, Kennedy JE, Higginbotham CL. 2011. Cytotoxic effects induced by unmodified and organically modified nanoclays in the human hepatic HepG2 cell line. J Appl Toxicol 31:27–35.
  • Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, Lynch I, 2011. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5:7503–7509.
  • Magdolenova Z, Bilaničová D, Pojana G, Fjellsbø LM, Hudecova A, Hasplova K, 2012. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit 4:455–464.
  • Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, 2011. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525–2534.
  • Mura S, Hillaireau H, Nicolas J, Le Droumaguet B, Gueutin C, Zanna S, 2011. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomedicine 6:2591–2605.
  • Oh JM, Choi SJ, Lee GE, Kim JE, Choy JH. 2009. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis. Chem Asian J 4:67–73.
  • Oh JM, Park CB, Choy JH. 2011. Intracellular drug delivery of layered double hydroxide nanoparticles. J Nanosci Nanotechnol 11:1632–1635.
  • Panas A, Marquardt C, Nalcaci O, Bockhorn H, Baumann W, Paur HR, 2012. Screening of different metal oxide nanoparticles reveals selective toxicity and inflammatory potential of silica nanoparticles in lung epithelial cells and macrophages. Nanotoxicology doi:10.3109/17435390.2011.652206.
  • Patel HA, Somani RS, Bajaj HC, Jasra RV. 2006. Nanoclays for polymer nanocomposties, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment. Bull Mater Sci 29:133–145.
  • Piret JP, Vankoningsloo S, Mejia J, Noël F, Boilan E, Lambinon F, 2011. Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape. Nanotoxicology 6(7):789–803.
  • Rabolli V, Thomassen LC, Uwambayinema F, Martens JA, Lison D. 2011. The cytotoxic activity of amorphous silica nanoparticles is mainly influenced by surface area and not by aggregation. Toxicol Lett 206:197–203.
  • Teppen BJ, Aggarwal V. 2007. Thermodynamics or organic cation exchange selectivity in smectites. Clay Minerals 55:119–130.
  • Wells MA, Abid A, Kennedy IM, Barakat AI. 2011. Serum proteins prevent aggregation of Fe(2)O(3) and ZnO nanoparticles. Nanotoxicology 6:837–846.
  • Xu X, Diang Y, Qian Z, Wang F, Wen B, Zhou H, 2009. Degradation of poly(ethylene terephthalate)/clay nanocomposites during melt extrusion: effect of clay catalysis and chain extension. Polym Degrada Stability 94:113–123.
  • Yang L, Rathman JF, Weavers LK. 2006. Sonochemical degradation of alkylbenzene sulfonate surfactants in aqueous mixtures. J Phys Chem B 110:18385–18391.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.